Skip to main content
OpenTrials

Clinical trial condition

Hemorrhagic Disorders

Explore clinical trials studying Hemorrhagic Disorders. Study availability and eligibility vary by location and protocol.

49 public trials 9 recruiting studies
Refine in advanced search Browse all conditions

Hemorrhagic Disorders trial results

Completed

A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF

NCT01787552

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +13 more
Locations
  • Novartis Investigative Site Camperdown, New South Wales, Australia
  • Novartis Investigative Site Woolloongabba, Queensland, Australia
  • Novartis Investigative Site Leuven, Belgium
  • Novartis Investigative Site Toronto, Ontario, Canada
View all 18 locations
View Trial Details
Completed

Exploratory Phase II Study of INC424 Patients With Primary Myelofibrosis (PMF) or Post Polycythaemia Myelofibrosis (PPV MF) or Post Essential Thrombocythaemia Myelofibrosis (PET-MF)

NCT01558739

Conditions
Blood Coagulation Disorders, Blood Platelet Disorders, Bone Marrow Diseases, +11 more
Locations
  • Novartis Investigative Site Cardiff, Wales, United Kingdom
  • Novartis Investigative Site Bournemouth, United Kingdom
  • Novartis Investigative Site East Yorkshire, United Kingdom
  • Novartis Investigative Site Edinburgh, United Kingdom
View Trial Details
Completed

Study of SGN-40 in Patients With Refractory or Recurrent Multiple Myeloma

NCT00079716

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • James R. Berenson M.D., Inc. West Hollywood, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Cornell University New York, United States
View Trial Details
Completed

Study of SGN-40, Lenalidomide, and Dexamethasone in Patients With Multiple Myeloma

NCT00525447

Conditions
Blood Coagulation Disorders, Blood Protein Disorders, Cardiovascular Diseases, +14 more
Locations
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • H. Lee Moffitt Cancer Center & Research Institute Tampa, Florida, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Barbara Ann Karmanos Cancer Institute Detroit, Michigan, United States
View Trial Details

Related conditions